2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors

LS Massad, MH Einstein, WK Huh… - Journal of lower …, 2013 - journals.lww.com
ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

[HTML][HTML] Clinical application of DNA ploidy to cervical cancer screening: A review

D Garner - World journal of clinical oncology, 2014 - ncbi.nlm.nih.gov
Screening for cervical cancer with DNA ploidy assessment by automated quantitative image
cytometry has spread throughout China over the past decade and now an estimated 1 …

Anal intraepithelial neoplasia: review and recommendations for screening and management

P Smyczek, AE Singh… - International journal of …, 2013 - journals.sagepub.com
Anal cancer is a rare malignancy of the distal gastrointestinal tract, often associated with
human papillomavirus, the most common sexually transmitted infection worldwide. Currently …

Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models

LL Reimers, WF Anderson, PS Rosenberg… - … Biomarkers & Prevention, 2009 - AACR
Background: Cervical carcinomas comprise two main histopathologic types, squamous cell
carcinomas and adenocarcinomas. Human papillomavirus (HPV) infections are causative …

Age‐specific patterns of unsatisfactory results for conventional Pap smears and liquid‐based cytology: data from two randomised clinical trials

PE Castle, J Bulten, M Confortini… - … Journal of Obstetrics …, 2010 - Wiley Online Library
Please cite this paper as: Castle P, Bulten J, Confortini M, Klinkhamer P, Pellegrini A,
Siebers A, Ronco G, Arbyn M. Age‐specific patterns of unsatisfactory results for conventional …

The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3

K Manley, A Patel, J Pawade, S Glew, K Hunt… - British Journal of …, 2022 - nature.com
Background Twenty percent of women referred to colposcopy have a type 3 transformation
zone—where colposcopic assessment for high-grade dysplasia (CIN2+) is not possible. This …

HPV Cotesting of unsatisfactory Papanicolaou tests: implications for follow-up intervals

F Chen, L Hsu Lin, I Hindi, W Sun… - American Journal of …, 2023 - academic.oup.com
Abstract Objectives The 2019 American Society of Colposcopy and Cervical Pathology
management guidelines recommend that patients with an unsatisfactory Papanicolaou …

The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic …

KM Clary, DD Davey, S Naryshkin… - … of pathology & …, 2013 - meridian.allenpress.com
Context.—The College of American Pathologists (CAP) conducted a national survey of
gynecologic cytology quality assurance (QA) practices. Experts in gynecologic cytology were …

Unsatisfactory SurePath liquid‐based Papanicolaou tests: causes and significance

M Alsharif, DM McKeon, HE Gulbahce… - … : A Journal of the …, 2009 - Wiley Online Library
BACKGROUND: The introduction of liquid‐based Papanicolaou (Pap) tests (LBPTs) has
reduced the incidence of unsatisfactory Pap tests (UPTs), but little is known about their …

[HTML][HTML] Improving the accuracy of a clinical decision support system for cervical cancer screening and surveillance

KE Ravikumar, KL MacLaughlin… - Applied clinical …, 2018 - thieme-connect.com
Background Clinical decision support systems (CDSS) for cervical cancer prevention are
generally limited to identifying patients who are overdue for their next routine/next screening …